Neuropsychiatr Dis Treat. 2014 Nov 14;10:2191-200. doi: 10.2147/NDT.S60854. eCollection 2014.
Clinical utility of implantable neurostimulation devices as adjunctive treatment of uncontrolled seizures.
Neuropsychiatric disease and treatment
Joanna H Cox, Stefano Seri, Andrea E Cavanna
Affiliations
Affiliations
- College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
- School of Life and Health Sciences, Aston Brain Centre, Aston University, Birmingham, UK ; Children's Epilepsy Surgery Programme, The Birmingham Children's Hospital NHS Foundation Trust, Birmingham, UK.
- College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK ; School of Life and Health Sciences, Aston Brain Centre, Aston University, Birmingham, UK ; Department of Neuropsychiatry, Birmingham and Solihull Mental Health NHS Foundation Trust, Birmingham, UK ; Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology and UCL, London, UK.
PMID: 25484587
PMCID: PMC4238748 DOI: 10.2147/NDT.S60854
Abstract
About one third of patients with epilepsy are refractory to medical treatment. For these patients, alternative treatment options include implantable neurostimulation devices such as vagus nerve stimulation (VNS), deep brain stimulation (DBS), and responsive neurostimulation systems (RNS). We conducted a systematic literature review to assess the available evidence on the clinical efficacy of these devices in patients with refractory epilepsy across their lifespan. VNS has the largest evidence base, and numerous randomized controlled trials and open-label studies support its use in the treatment of refractory epilepsy. It was approved by the US Food and Drug Administration in 1997 for treatment of partial seizures, but has also shown significant benefit in the treatment of generalized seizures. Results in adult populations have been more encouraging than in pediatric populations, where more studies are required. VNS is considered a safe and well-tolerated treatment, and serious side effects are rare. DBS is a well-established treatment for several movement disorders, and has a small evidence base for treatment of refractory epilepsy. Stimulation of the anterior nucleus of the thalamus has shown the most encouraging results, where significant decreases in seizure frequency were reported. Other potential targets include the centromedian thalamic nucleus, hippocampus, cerebellum, and basal ganglia structures. Preliminary results on RNS, new-generation implantable neurostimulation devices which stimulate brain structures only when epileptic activity is detected, are encouraging. Overall, implantable neurostimulation devices appear to be a safe and beneficial treatment option for patients in whom medical treatment has failed to adequately control their epilepsy. Further large-scale randomized controlled trials are required to provide a sufficient evidence base for the inclusion of DBS and RNS in clinical guidelines.
Keywords: deep brain stimulation; epilepsy; implantable neurostimulation device; responsive neurostimulation; seizures; vagus nerve stimulation
References
- Behav Neurol. 2011;24(1):35-41 - PubMed
- Lancet Neurol. 2002 Dec;1(8):477-82 - PubMed
- Discov Med. 2010 Feb;9(45):138-44 - PubMed
- Nat Rev Neurosci. 2007 Aug;8(8):623-35 - PubMed
- Epilepsia. 2007 Aug;48(8):1561-71 - PubMed
- Neurosurg Focus. 2010 Aug;29(2):E8 - PubMed
- CNS Drugs. 2012 Apr 1;26(4):319-35 - PubMed
- Epilepsia. 2007 Oct;48(10):1895-903 - PubMed
- Seizure. 2009 Oct;18(8):588-92 - PubMed
- Neurology. 2006 May 23;66(10):1490-4 - PubMed
- Acta Neurochir (Wien). 1976;(23 Suppl):257-62 - PubMed
- Epilepsia. 2005 Jul;46(7):1071-81 - PubMed
- Neurosurgery. 2008 Feb;62 Suppl 2:506-13 - PubMed
- Neurol Clin. 2009 Nov;27(4):1003-13 - PubMed
- Epilepsia. 2002 Jun;43(6):603-8 - PubMed
- Seizure. 2011 Jul;20(6):485-90 - PubMed
- Pediatr Neurol. 2006 Nov;35(5):323-6 - PubMed
- Epilepsia. 2006 Jul;47(7):1203-12 - PubMed
- Epilepsia. 2001 Sep;42(9):1148-52 - PubMed
- Epilepsia. 2013 Oct;54(10):1823-33 - PubMed
- Neurol Res. 2000 Apr;22(3):247-58 - PubMed
- Epilepsia. 2010 Feb;51(2):304-7 - PubMed
- Ann Neurol. 2002 Nov;52(5):556-65 - PubMed
- JAMA Neurol. 2013 Feb;70(2):163-71 - PubMed
- Trans Am Neurol Assoc. 1973;98:192-6 - PubMed
- Ann Pharmacother. 2012 Feb;46(2):248-54 - PubMed
- Epilepsia. 2014 Apr;55(4):475-82 - PubMed
- Int J Neural Syst. 2013 Feb;23(1):1250034 - PubMed
- Epilepsia. 2007 Aug;48(8):1551-60 - PubMed
- Ann Neurol. 2005 Feb;57(2):258-68 - PubMed
- J Clin Neurophysiol. 2004 Jul-Aug;21(4):283-9 - PubMed
- J Cent Nerv Syst Dis. 2012 Jun 19;4:105-15 - PubMed
- Clin Neurol Neurosurg. 2004 Sep;106(4):318-29 - PubMed
- Seizure. 2012 Apr;21(3):183-7 - PubMed
- Behav Neurol. 2011;24(1):43-6 - PubMed
- Acta Neurochir Suppl. 2006;99:87-91 - PubMed
- Neurosurgery. 2000 Aug;47(2):295-304; discussion 304-5 - PubMed
- Curr Behav Neurosci Rep. 2014 Jun;1(2):64-73 - PubMed
- Ther Adv Neurol Disord. 2011 Nov;4(6):385-407 - PubMed
- Seizure. 2014 Jan;23(1):6-9 - PubMed
- Epilepsia. 2000 Sep;41(9):1195-200 - PubMed
- Neurosurg Focus. 2012 Mar;32(3):E13 - PubMed
- Chin Med J (Engl). 2013;126(17):3364-70 - PubMed
- Epilepsy Behav. 2013 Nov;29(2):416-9 - PubMed
- Neurology. 2011 Sep 27;77(13):1295-304 - PubMed
- Stereotact Funct Neurosurg. 2010;88(5):281-7 - PubMed
- Epilepsia. 1995 Jan;36(1):63-71 - PubMed
- Seizure. 2004 Apr;13(3):176-8 - PubMed
- J Neurol Neurosurg Psychiatry. 1984 Aug;47(8):769-74 - PubMed
- Pediatr Int. 2001 Feb;43(1):61-5 - PubMed
- Mov Disord. 2008 Nov 15;23(15):2111-21 - PubMed
- Stereotact Funct Neurosurg. 2012;90(6):379-85 - PubMed
- Arch Neurol. 1976 Aug;33(8):559-70 - PubMed
- Eur J Paediatr Neurol. 2007 Sep;11(5):261-9 - PubMed
- Seizure. 2013 Jun;22(5):390-5 - PubMed
- Isr Med Assoc J. 2013 Nov;15(11):673-7 - PubMed
- Stereotact Funct Neurosurg. 2001;77(1-4):228-32 - PubMed
- Neuromodulation. 2013 Nov-Dec;16(6):551-6; discussion 556 - PubMed
- Epilepsia. 1992 Sep-Oct;33(5):841-51 - PubMed
- Dev Med Child Neurol. 2012 Sep;54(9):855-61 - PubMed
- Epileptic Disord. 2002 Dec;4 Suppl 3:S83-93 - PubMed
- Neurosurgery. 1977 Sep-Oct;1(2):203-5 - PubMed
- Epilepsia. 2011 Jun;52(6):1052-7 - PubMed
- Epilepsy Behav. 2011 Jan;20(1):57-63 - PubMed
- Seizure. 2011 May;20(4):331-5 - PubMed
- Epilepsy Behav. 2011 Mar;20(3):478-83 - PubMed
- Brain Res Bull. 2013 Aug;97:39-47 - PubMed
- Epilepsy Res. 2012 Feb;98(2-3):135-9 - PubMed
- Epilepsia. 2006 Jul;47(7):1239-41 - PubMed
- Epilepsia. 2011 Jun;52(6):1058-62 - PubMed
- Lancet Neurol. 2012 Sep;11(9):814-26 - PubMed
- Front Syst Neurosci. 2014 Mar 14;8:33 - PubMed
- Epilepsia. 2004 Apr;45(4):346-54 - PubMed
- Neurology. 1999 Nov 10;53(8):1731-5 - PubMed
- Epilepsia. 2009 Dec;50(12):2671-2 - PubMed
- Stereotact Funct Neurosurg. 1997;69(1-4 Pt 2):221-4 - PubMed
- Epilepsia. 2010 May;51(5):899-908 - PubMed
- Neurology. 1995 Feb;45(2):224-30 - PubMed
- Nat Rev Neurol. 2009 May;5(5):267-76 - PubMed
- Pediatr Neurol. 2001 Sep;25(3):213-6 - PubMed
- Epilepsia. 2005;46 Suppl 5:98-9 - PubMed
- Acta Neurochir (Wien). 2010 Dec;152(12):2053-62 - PubMed
- Neurology. 2002 Nov 12;59(9):1421-4 - PubMed
- Stereotact Funct Neurosurg. 1990;54-55:56-9 - PubMed
- Neurosurg Focus. 2008 Sep;25(3):E12 - PubMed
- Br J Neurosurg. 2011 Feb;25(1):38-44 - PubMed
- Electroencephalogr Clin Neurophysiol Suppl. 1978;(34):349-54 - PubMed
- J Clin Psychopharmacol. 2012 Jun;32(3):362-75 - PubMed
- Epilepsy Behav. 2014 Jan;30:38-42 - PubMed
- Neurology. 2012 May 15;78(20):1548-54 - PubMed
- Lancet Neurol. 2012 Jan;11(1):5-7 - PubMed
- Epilepsia. 2007 Feb;48(2):342-7 - PubMed
- Seizure. 2010 Jun;19(5):264-8 - PubMed
- Neurology. 1998 Jul;51(1):48-55 - PubMed
Publication Types